UK regulator reports 30 cases of rare blood clot events after AstraZeneca jab

Regulators said that the public should continue to take up the vaccine when offered it (Yui Mok/PA)

British regulators said they have identified 30 cases of rare blood clot events associated with the AstraZeneca vaccine but stressed the benefits of the jab in preventing coronavirus outweigh any risks.

The UK Medicines and Healthcare Regulatory Agency (MHRA) said on Thursday that the risk associated with this type of blood clot is “very small” and that the public should continue to take up the vaccine when offered it.